Targeting Physical AI Components… SamsungElectroMechanics and LG Innotek’s R&D Spending Nears 900 Billion Won
SamsungElectroMechanics: 474.1 billion, LG Innotek: 407.3 billion… Up 18.2% Year-Over-Year
Expanding from MLCCs and FC-BGAs for AI Servers to Robot Sensing and Control
AI Applied to Development and Production Processes… Defect Prediction and Process Optimization
Expectations for Improved Earnings in the Second Half Amid Growing Demand for High-Value-Added Components
[Edaily Reporter JAEMIN SONG ] SamsungElectroMechanics and LG Innotek are expanding the technologies they have accumulated in mobile and IT components into the fields of AI servers, autonomous driving, and humanoid robots. They are boosting competitiveness across their entire business by significantly increasing investment in research and development (R&D) while also applying AI to their development and production sites.
SamsungElectroMechanics’ Suwon headquarters. (Photo courtesy of SamsungElectroMechanics) According to the Financial Supervisory Service’s electronic disclosure system on the 20th, SamsungElectroMechanics and LG Innotek’s combined R&D expenses for the first half of this year totaled 881.5 billion won, an 18.2% increase from the same period last year (746.0 billion won). If the current trend is simply extrapolated on an annualized basis, the figure would exceed 1.76 trillion won.
SamsungElectroMechanics’ R&D expenses for the first half totaled 474.1 billion won, a 26.0% increase from the same period last year. The ratio of R&D expenses to revenue also rose from 6.8% to 7.1%. SamsungElectroMechanics is focusing on the development of high-value-added products, such as ultra-high-capacity multilayer ceramic capacitors (MLCCs) for AI servers and data centers, flip-chip ball grid arrays (FC-BGA) for AI accelerators, and camera modules for autonomous driving.
LG Innotek invested 407.3 billion won in R&D during the first half of the year, a 10.2% increase compared to the same period last year. Although the proportion of R&D spending relative to revenue fell from 4.1% to 3.7% as revenue grew at a faster pace, the investment amount itself saw double-digit growth. The company is fostering next-generation substrates and advanced packaging for AI servers and high-performance computing (HPC), as well as multi-sensor systems for autonomous driving and sensing and control solutions for humanoid robots, as new growth engines.
Both companies are not only supplying AI components but are also integrating AI into their research, development, and production processes. SamsungElectroMechanics operates an “AI Solutions Team” and an “Agentic AI Development Task Force” dedicated to streamlining AI-based development and manufacturing. LG Innotek uses AI to predict process defects and derive optimal production recipes, and by applying AI vision to incoming raw material inspections, it has reduced the time required to analyze defect causes by 90% compared to previous methods.
This expansion of investment is expected to lead to improved financial performance. SamsungElectroMechanics forecast its best-ever third-quarter results, driven by demand for AI data centers and autonomous driving components. SamsungSecurities noted that LG Innotek’s AI semiconductor substrate utilization rate is nearing 100% and predicted that its operating profit for the second half of this year will reach its highest level since the second half of 2021.
An industry official stated, “In the AI and physical AI markets, customers demand high levels of performance and reliability, and product cycles are fast,” adding, “How quickly companies can complete technology validation through proactive R&D will determine their competitiveness in securing future orders.”
SamsungElectroMechanics and LG Innotek are expanding the technologies they have accumulated in mobile and IT components into the fields of AI servers, autonomous driving, and humanoid robots. They are…
HARIM Co., Ltd.(136480)expanded its broiler business in the first half of this year, driven by rising chicken prices, but its profitability deteriorated significantly. This was due to higher live chic…
AprilBio Co.,Ltd.(397030)Since “APB-A1” (Lu AG22515), which was licensed to Lundbeck, failed to demonstrate the expected clinical efficacy in thyroid-associated ophthalmopathy (TED), the company is no…